Abstract:Propofol is frequently used for anesthesia in cancer surgery. It has been suggested that treatment with propofol serves a tumor-suppressing role in human gastric cancer (GC). Therefore, the present study aimed to explore the potential mechanism of propofol in GC. In the present study, GC cell lines (HGC-27 and AGS) were treated with various concentrations of propofol, and an MTT assay was performed to detect the cell viability. In addition, flow cytometry and Transwell assays were used to evaluate the apoptosis and invasive ability of GC cells, respectively. Western blotting was performed to detect the protein levels of cyclin-dependent kinase inhibitor P21 (P21), B-cell lymphoma-2 (Bcl-2), matrix metalloproteinase 9 (MMP9) and E26 oncogene homolog 1 (ETS1). Furthermore, reverse transcription-quantitative PCR was used to examine the expression levels of circular RNA-PVT1 (circ-PVT1), micoRNA-195-5p (miR-195-5p) and ETS1 in GC tissues and cells. The target interaction between miR-195-5p and circ-PVT1 or ETS1 was predicted through bioinformatics analysis, and verified by dual-luciferase reporter gene assay. In addition, a mouse xenograft model was established for in vivo experiments. It was identified that propofol inhibited the viability and invasion, but promoted apoptosis of HGC-27 and AGS cells in a dose-dependent manner. Propofol could inhibit Bcl-2 and MMP9 expression, and increase P21 expression in GC cells. The expression levels of circ-PVT1 and ETS1 were increased in GC tissues and cells, and miR-195-5p was decreased. Additionally, the treatment with propofol could lead to decreased circ-PVT1 expression in GC cells. These results could be reversed by ETS1 upregulation or miR-195-5p-knockdown in GC cells. Furthermore, circ-PVT1 could act as a miR-195-5p sponge to modulate ETS1 expression. Additionally, the effects of transfection with circ-PVT1 small interfering RNA (si-circ-PVT1) on HGC-27 and AGS cells could be reversed by treatment with miR-195-5p inhibitor. Meanwhile, miR-195-5p inhibitor reversed the si-circ-PVT1-induced low expression of ETS1. Downregulation of ETS1 induced by propofol in HGC-27 and AGS cells could be restored by circ-PVT1 upregulation or miR-195-5p silencing. Circ-PVT1 silencing facilitated the propofol-induced anti-GC effect in vivo. In conclusion, the present study indicated that propofol inhibited the proliferation and invasion, but enhanced the apoptosis of GC cells by regulating the circ-PVT1/miR-195-5p/ETS1 axis.

Propofol suppresses proliferation and metastasis of colorectal cancer cells by regulating miR-124-3p.1/AKT3

Propofol Inhibits Proliferation, Migration, Invasion and Promotes Apoptosis Through Down-Regulating Mir-374A in Hepatocarcinoma Cell Lines

Propofol Exerts Anti-Hepatocellular Carcinoma by Microvesicle-Mediated Transfer of Mir-142-3p from Macrophage to Cancer Cells

Effects of Propofol on Colon Cancer Metastasis Through STAT3/HOTAIR Axis by Activating WIF‐1 and Suppressing Wnt Pathway

Propofol Inhibits the Adhesion of Hepatocellular Carcinoma Cells by Upregulating Microrna-199A and Downregulating MMP-9 Expression.

Propofol suppresses colorectal cancer development by the circ-PABPN1/miR-638/SRSF1 axis

The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the NF-κB/HIF-1α Signaling Pathway

Propofol-induced LINC01133 inhibits the progression of colorectal cancer via miR-186-5p/NR3C2 axis

Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression.

Propofol Facilitates Cisplatin Sensitivity Via Lncrna MALAT1/miR-30e/ATG5 Axis Through Suppressing Autophagy in Gastric Cancer.

Propofol inhibits colon cancer cell stemness and epithelial-mesenchymal transition by regulating SIRT1, Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways

Anesthetic Propofol Promotes Tumor Metastasis in Lungs via GABA<sub>A</sub>R‐Dependent TRIM21 Modulation of Src Expression

RETRACTED: Propofol Inhibits Proliferation, Migration and Invasion of Gastric Cancer Cells by Up-Regulating Microrna-195

Anesthetic Propofol Promotes Tumor Metastasis in Lungs Via GABAAR‐Dependent TRIM21 Modulation of Src Expression

Anesthetic Drug Propofol Inhibits the Expression of Interleukin-6, Interleukin-8 and Cyclooxygenase-2, a Potential Mechanism for Propofol in Suppressing Tumor Development and Metastasis.

Propofol suppresses non-small cell lung cancer progression by modulating circ_0001727/miR-516b-5p/LRRC1 axis

Propofol Suppresses Gastric Cancer Tumorigenesis by Modulating the Circular RNA‑PVT1/miR‑195‑5p/E26 Oncogene Homolog 1 Axis

Effect of propofol on lung metastasis of circulating tumor cells after colorectal cancer surgery

Propofol Inhibits Proliferation and Invasion of Stomach Cancer Cells by Regulating miR-205/YAP1 Axis

Propofol Inhibits the Migration and Invasion of Glioma Cells by Blocking the PI3K/AKT Pathway Through miR-206/ROCK1 Axis.

Mechanism of Propofol Inhibiting Proliferation of Colorectal Cancer by Down-Regulating BNIPL-2